TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioSalma AB
Closing information (x1000 EUR)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
16,344
|
9,721
|
6,747 |
| Financial expenses |
5
|
1
|
0 |
| Earnings before taxes |
4,560
|
2,231
|
1,424 |
| EBITDA |
4,519
|
2,192
|
1,431 |
| Total assets |
8,621
|
5,720
|
4,121 |
| Current assets |
8,595
|
5,714
|
4,107 |
| Current liabilities |
3,781
|
1,362
|
1,644 |
| Equity capital |
4,840
|
4,358
|
2,477 |
| - share capital |
5
|
4
|
4 |
| Employees (average) |
6
|
6
|
5 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
56.1%
|
76.2%
|
60.1% |
| Turnover per employee |
2,724
|
1,620
|
1,349 |
| Profit as a percentage of turnover |
27.9%
|
23.0%
|
21.1% |
| Return on assets (ROA) |
53.0%
|
39.0%
|
34.6% |
| Current ratio |
227.3%
|
419.5%
|
249.8% |
| Return on equity (ROE) |
94.2%
|
51.2%
|
57.5% |
| Change turnover |
6,376
|
2,672
|
2,381 |
| Change turnover % |
64%
|
38%
|
55% |
| Chg. No. of employees |
0
|
1
|
1 |
| Chg. No. of employees % |
0%
|
20%
|
25% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.